"And that the DSMC that Amarex chose, and we rubber stamped, was ineffective at best. And very likely the member with strong GILD ties exercised their influence to ensure that we did not have the guidance that would have lead to a successful trial."

Dr Frederick G. Hayden, virologist and immunologist from Virginia.

Read More: https://investorshangout.com/post/view?id=630...z7FA7oj4q3